Tenascin-C nucleic acid ligands

Details Tenascin-C nucleic acid ligands Tenascin-C nucleic acid ligands

2006-02-28

2006-02-28

Forman, B J (Department: 1634)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S007100, C435S091100, C536S023100, C536S024300, C536S025300, C536S026500

Reexamination Certificate

active

07005260

ABSTRACT:
Methods are described for the identification and preparation of nucleic acid ligands to tenascin-C. Included in the invention are specific RNA ligands to tenascin-C identified by the SELEX method. Further included in the invention are methods for detecting the presence of a disease condition in a biological tissue in which tenascin-C is expressed.

REFERENCES:
patent: 5436132 (1995-07-01), Kimura et al.
patent: 5475096 (1995-12-01), Gold et al.
patent: 5496938 (1996-03-01), Gold
patent: 5582981 (1996-12-01), Toole et al.
patent: 5723323 (1998-03-01), Kauffman et al.
patent: 5789157 (1998-08-01), Jensen et al.
patent: 5859228 (1999-01-01), Janjic et al.
patent: 6127119 (2000-10-01), Stephens et al.
patent: 6232071 (2001-05-01), Hicke et al.
patent: 6242246 (2001-06-01), Gold et al.
patent: 6596491 (2003-07-01), Hicke et al.
patent: 6610841 (2003-08-01), Warren
patent: 2 183 661 (1987-06-01), None
patent: WO 89/06694 (1989-07-01), None
patent: WO 91/19813 (1991-12-01), None
patent: WO 92/14843 (1992-09-01), None
patent: WO 99/30561 (1999-06-01), None
Bigner et al. (Jun. 1998) Journal of Clinical Oncology 16:2202-2212.
Ellington & Szostak (May 1990) Abstracts of papers presented at the 1990 meeting on RNA Processing, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, p. 84.
Joyce & Inoue (1989) Nucleic Acids Research 17:711-722.
Joyce (1989) Gene 82:83-87.
Kinzler & Vogelstein (1989) Nucleic Acids Research 17:3645-3653.
Kramer et al. (1974) J. Mol. Biol. 89:719.
Levisohn & Spiegelman (1969) Proc. Natl. Acad. Sci. USA 63:805-811.
Lovisohn & Spiegelman (1968) Proc. Natl. Acad. Sci. USA 60:866-872.
Merlo et al. (1997) Int. J. Cancer 71:810-816.
Oliphant et al. (Jul. 1989) Mol. Cell Biol. 9:2944-2949.
Oliphant & Struhl (1988) Nucleic Acids Research 16:7673-7683.
Oliphant & Struhl (1987) Methods in Enzymology 155:568-582.
Oliphant et al. (1986) Gene 44:177-183.
Paganelli et al. (Apr. 1999) Eur. J. Nucl. Med. 26:348-357.
Paganelli et al. (Apr. 1994) Eur. J. Nucl. Med. 21:314-321.
Robertson & Joyce (Mar. 1990) Nature 344:467-468.
Szostak, “Structure and Activity of Ribozymes,” inRedesigning the Molecules of Life, (S.A. Benner, ed.) Springer-Verlag Berline Heidelberg, pp. 87-113, (1988).
Thiesen & Bach (1990) Nucleic Acids Research 18:3203-3208.
Klung, and Famulok (1994) Molecular Biology Reports 20: 97-107 Incomplete.
Nobile et al. (May 1998) Biochemistry 37:6857-6863.
Polisky (Dec. 1997) The Many Faces of RNA 161-177.
Hicke et al., Journal of Nuclear Medicine 40 (5):99 (May, 1999).
Slide presented by Brian Hicke at the Society of Nuclear Medicine's Annual Meeting, Jun. 7-10, 1999, Los Angeles, CA.
Hicke et al., J. Biol. Chem. 276 (52): 48644-48654 (2001).
Bourdon et al., (1984)Anticancer Res.4(3):133-40.
Clarke, (1996)Breast Cancer Res Treat. 39:69-86.
Heikinheimo et al., (1991)Virchows Arch B Cell Pathol Incl Mol Pathol.61(2):101-9.
Hjelstuen, (1995)Analyst. 120: 863-866.
Ishihara et al., (1995)Clin. Cancer Res. 1:1035-1041.
Jahkola et al., (1998)Eur. J. Cancer 34:1687-1692.
Jahkola et al., (1998)Br. J. Cancer 78:1507-1513.
Reardon et al., (2002)J Clin Oncol.20(5):1389-97.
Rofstad & Lyng, (1996)Mol Med Today. 2:394-403.
Schnyder et al., (1997)Int J Cancer.17;72(2):217-24.
Schold et al., (1993)Invest Radiol.28(6):488-96.
Soini et al., (1992)Virchows Arch A Pathol Anat Histopathol., 421(3):217-22.
Stamp,J Pathol.(1989) Nov.;159(3):225-9.
Thompson et al., (1998)Biochim Biophys Acta. 1400(1-3):301-19.
Tiita et al., (1993)Virchow Arch B Cell Pathol Incl Mol Pathol.63(5):283-7.
Vollmer et al., (1990)Lab Invest., 62(6):725-30.
Yamada et al., (1992)Liver, 12(1):10-6.
Zalutsky et al., (1989)Cancer Res.15;49(10):2807-13.

Affiliated with

Also associated with

Rating

Tenascin-C nucleic acid ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tenascin-C nucleic acid ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tenascin-C nucleic acid ligands will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3701265